Bigfoot Biomedical

Bigfoot Biomedical is a new type of medical device company dedicated to developing technologies that significantly reduce the cognitive, emotional, and financial burdens of insulin-dependent diabetes. Bigfoot places a high emphasis on ease of use, optimizing insulin dosing and delivery through an integrated ecosystem of medical devices powered by machine learning and enhanced by secure, user-friendly consumer technology, fundamentally transforming the care paradigm. The company’s groundbreaking smartphone system includes an automated insulin pump for consumers and connected insulin pen options, delivered through a first-of-its-kind monthly subscription service model. Bigfoot will be the first company to offer a monthly subscription-based service utilizing an intelligent, connected insulin delivery platform to meet the needs of different populations requiring insulin. Bigfoot’s research system leverages intuitive design, machine learning technology, and mobile applications running on off-the-shelf smartphones to keep users' glucose levels within an optimal range.